Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Khwaja, Sadie, Kumar, Balasubrahmanyam, Philpott, Carl ORCID: https://orcid.org/0000-0002-1125-3236 and Strachan, David P. (2019) Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. UNSPECIFIED.

Full text not available from this repository. (Request a copy)

Item Type:	Other
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Respiratory and Airways Group Faculty of Medicine and Health Sciences > Research Centres > Mental Health and Social Care (fka Lifespan Health) Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health
Depositing User:	LivePure Connector
Date Deposited:	19 Dec 2019 04:22
Last Modified:	18 Jun 2026 21:21
URI:	https://ueaeprints.uea.ac.uk/id/eprint/73402
DOI:	10.1016/S0140-6736(19)31881-1

Actions (login required)

View Item